Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-08

Clinical Trial Update: A Study of RX-10045 in the Treatment of Dry Eye Disease [Phase 2]

View source ↗

Summary

The document reports completion of a Phase 2 clinical trial evaluating RX-10045 for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RX-10045

Snippet

Sponsor: C.T. Development America, Inc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED